Skip to content
Clinivis
Demonstration workspace · synthetic patients · supports, and does not replace, professional clinical judgement
Panel
HB

Harold Bennett

High · 61

Harry · 82M · DOB 2 Dec 1943 · MRN RN-33018

Parkinson's disease with three falls in four months. Anticholinergic burden from oxybutynin and PRN quetiapine is the main iatrogenic driver.

Falls & bone health

Allergies: Codeine (nausea)

For ward-based care · not for CPR · ReSPECT 2026-01

Oxybutynin — Beers, ACB, falls

Strong anticholinergic in MCI and Parkinson's. First deprescribing target.

PRN quetiapine

Antipsychotics increase stroke, fall and mortality risk in this phenotype.

Postural hypotension

32 mmHg systolic drop at 3 minutes on tamsulosin.

Clinical parameters

Sodium

134mmol/L

Ref 135–145

Vitamin D

46nmol/L

Ref >50

Haemoglobin

129g/L

Ref 130–170

Organ risk

Conditions

Parkinson's disease

Hoehn & Yahr 3

2018-05

Recurrent falls

2026-05

BPH

2015

Mild cognitive impairment

2024-11

Constipation

2019

Care team

Dr Ruth Klein

Geriatric medicine

James Cole

Clinical pharmacist

Amira Khan

Parkinson's CNS

Next encounter

Parkinson's + pharmacy review

Mon 21 Sep · 09:40

Riverside · Room 2 · Dr Klein & J. Cole